Lumen Bioscience Inc. plans to use its $11.2 million in series A money – supplemented by $1.8 million in the form of a grant from the U.S. Department of Energy – to explore the use of spirulina in making therapeutic products, CEO and co-founder Brian Finrow told BioWorld Insight. Read More
The California life sciences sector continues to flourish and remains an engine of innovation for the state according to the latest 2018 California Life Sciences Industry Report. The current data reveals that there has been an annual 6 percent growth in the number of enterprises with about 45 percent of the 3,249 companies that are operating in California focused on biotechnology and pharmaceuticals, and there are 1,796 device and medical equipment manufacturers (55 percent). Read More